Literature DB >> 12099892

The neglected constituent of the basal forebrain corticopetal projection system: GABAergic projections.

Martin Sarter1, John P Bruno.   

Abstract

At least half of the basal forebrain neurons which project to the cortex are GABAergic. Whilst hypotheses about the attentional functions mediated by the cholinergic component of this corticopetal projection system have been substantiated in recent years, knowledge about the functional contributions of its GABAergic branch has remained extremely scarce. The possibility that basal forebrain GABAergic neurons that project to the cortex are selectively contacted by corticofugal projections suggests that the functions of the GABAergic branch can be conceptualized in terms of mediating executive aspects of cognitive performance, including the switching between multiple input sources and response rules. Such speculations gain preliminary support from the effects of excitotoxic lesions that preferentially, but not selectively, target the noncholinergic component of the basal forebrain corticopetal system, on performance in tasks involving demands on cognitive flexibility. Progress in understanding the cognitive functions of the basal forebrain system depends on evidence regarding its main noncholinergic components, and the generation of such evidence is contingent on the development of methods to manipulate and monitor selectively the activity of the GABAergic corticopetal projections.

Mesh:

Substances:

Year:  2002        PMID: 12099892     DOI: 10.1046/j.1460-9568.2002.02004.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  31 in total

Review 1.  The thalamo-cortical auditory receptive fields: regulation by the states of vigilance, learning and the neuromodulatory systems.

Authors:  Jean-Marc Edeline
Journal:  Exp Brain Res       Date:  2003-09-27       Impact factor: 1.972

Review 2.  Mechanisms of deep brain stimulation.

Authors:  Todd M Herrington; Jennifer J Cheng; Emad N Eskandar
Journal:  J Neurophysiol       Date:  2015-10-28       Impact factor: 2.714

3.  GABA immunoreactivity in auditory and song control brain areas of zebra finches.

Authors:  Raphael Pinaud; Claudio V Mello
Journal:  J Chem Neuroanat       Date:  2007-03-27       Impact factor: 3.052

4.  Tone-specific and nonspecific plasticity of the auditory cortex elicited by pseudoconditioning: role of acetylcholine receptors and the somatosensory cortex.

Authors:  Weiqing Ji; Nobuo Suga
Journal:  J Neurophysiol       Date:  2008-07-02       Impact factor: 2.714

Review 5.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

6.  Long-Range GABAergic Inhibition Modulates Spatiotemporal Dynamics of the Output Neurons in the Olfactory Bulb.

Authors:  Pablo S Villar; Ruilong Hu; Ricardo C Araneda
Journal:  J Neurosci       Date:  2021-03-08       Impact factor: 6.167

7.  Cholinergic basal forebrain structure influences the reconfiguration of white matter connections to support residual memory in mild cognitive impairment.

Authors:  Nicola J Ray; Claudia Metzler-Baddeley; Mizanur R Khondoker; Michel J Grothe; Stefan Teipel; Paul Wright; Helmut Heinsen; Derek K Jones; John P Aggleton; Michael J O'Sullivan
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

8.  Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance.

Authors:  Ramalingam Vetrivelan; Mei-Hong Qiu; Celene Chang; Jun Lu
Journal:  Front Neuroanat       Date:  2010-11-23       Impact factor: 3.856

9.  Parvalbumin-immunoreactive neurons and GABAergic neurons of the basal forebrain project to the rat basolateral amygdala.

Authors:  F Mascagni; A J McDonald
Journal:  Neuroscience       Date:  2009-03-11       Impact factor: 3.590

10.  Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats.

Authors:  Karen E Boschen; Jim R Fadel; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2009-07-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.